The Scotts Miracle-Gro Company (SMG) Stock Forecast
SMG analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.38 / 5 from 8 analysts
- Price target
- $72.83 average of analyst targets
- Upside to target
- +33.5% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $-2.22
- 52-week range
- $48.44 – $73.47
SMG analyst ratings
8 analystsNumber of analysts at each rating.
SMG price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SMG earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | −$0.71 | −$0.86 | −$0.53 | −$0.77 | +7.1% | 4 |
| Current fiscal year (FY2026) | $4.41 | $4.30 | $4.50 | $3.74 | +18.0% | 8 |
| Next fiscal year (FY2027) | $4.69 | $4.09 | $5.00 | $4.41 | +6.3% | 8 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SMG revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next quarter (Dec '26) | $362.9M | $361.7M | $364.0M | +2.4% | 4 |
| Current fiscal year (FY2026) | $3.29B | $3.27B | $3.30B | −3.6% | 8 |
| Next fiscal year (FY2027) | $3.36B | $3.31B | $3.39B | +2.2% | 8 |
SMG EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SMG revenue: reported and forecast
SMG EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | −$0.73 | −$0.72 | −$0.72 | −$0.73 | −$0.71 | −1.4% | 3 up · 2 down |
| Current fiscal year (FY2026) | $4.35 | $4.42 | $4.42 | $4.42 | $4.41 | +1.6% | 5 up · 1 down |
| Next fiscal year (FY2027) | $4.71 | $4.73 | $4.73 | $4.70 | $4.69 | −0.4% | 4 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SMG earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SMG beat in 10 of 12.
What analysts expect from SMG
8 analysts cover Scotts Miracle-Gro; their consensus rating is buy (4.38 on a 1–5 scale, where 5 is a strong buy). The average price target is $72.83, 33.5% above the latest close of $54.57. Analysts expect earnings of $4.41 per share for FY2026, +18.0% from a year earlier. For FY2027 the average estimate is $4.69 per share on revenue of $3.4 billion. Scotts Miracle-Gro beat the EPS estimate in 10 of the last 12 quarters.
Related: SMG income statement, SMG key metrics, SMG chart. See the SMG stock overview for the latest quote and news.
SMG forecast FAQ
What is Scotts Miracle-Gro's price target?
The average analyst price target for Scotts Miracle-Gro is $72.83, 33.5% above the latest close of $54.57.
Is Scotts Miracle-Gro a buy, hold or sell?
Of 8 analysts covering Scotts Miracle-Gro, 5 rate it a strong buy, 1 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Scotts Miracle-Gro's EPS forecast?
Analysts forecast $4.41 per share for FY2026 (range $4.30 to $4.50); for FY2027 the estimate is $4.69.
What is Scotts Miracle-Gro's revenue forecast?
The average revenue estimate for FY2026 is $3.3 billion, growth of −3.6%; for FY2027 it is $3.4 billion.
When does Scotts Miracle-Gro report earnings?
Scotts Miracle-Gro is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $-2.22.
Does Scotts Miracle-Gro usually beat earnings estimates?
Scotts Miracle-Gro reported EPS at or above the analyst estimate in 10 of the last 12 quarters.